NET PROFIT (x1000 NOK)
EMPLOYEES
TILT Biotherapeutics Oy
Closing information (x1000 NOK)
| Closing information | 2016/12 | 2015/12 | 2014/12 |
| Financial expenses |
1,318
|
19
|
0 |
| Earnings before taxes |
-12,648
|
-3,671
|
-796 |
| Total assets |
37,336
|
17,531
|
2,868 |
| Current assets |
37,008
|
17,311
|
2,108 |
| Current liabilities |
1,090
|
669
|
235 |
| Equity capital |
25,142
|
12,035
|
1,285 |
| - share capital |
27
|
29
|
27 |
| Employees (average) |
7
|
3
|
2 |
Financial ratios
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Solvency |
67.3%
|
68.6%
|
44.8% |
| Turnover per employee | |||
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-30.3%
|
-20.8%
|
-27.8% |
| Current ratio |
3395.2%
|
2587.6%
|
897.0% |
| Return on equity (ROE) |
-50.3%
|
-30.5%
|
-61.9% |
| Change turnover | |||
| Change turnover % | |||
| Chg. No. of employees |
4
|
1
|
0 |
| Chg. No. of employees % |
133%
|
50%
|
0% |
Total value of public sale
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.